哮喘治疗的患者偏好：一项离散选择实验。
Patient preferences for asthma therapy: a discrete choice experiment.
作者信息
Lloyd Andrew, McIntosh Emma, Rabe Klaus F, Williams Angela
机构信息
Deputy Director Europe, United BioSource Corporation, 20 Bloomsbury Square, London, WC1A 2NS, UK.
出版信息
Prim Care Respir J. 2007 Aug;16(4):241-8. doi: 10.3132/pcrj.2007.00052.
AIM
This study was designed to capture patient preferences for different aspects of asthma treatment from people with asthma in the UK, the Netherlands and Spain.
METHODS
Asthma patients from the UK (n=124), the Netherlands (n=269) and Spain (n=86) participated in the survey. Patients' preferences and willingness to pay for a particular number of preventer inhalers, in relation to days per week with symptoms, days requiring reliever medication, risk of side effects, and requirement for a visit to their general practitioner (GP) or the Emergency Room (ER), were recorded.
RESULTS
Participants were willing to pay euro 35/month to avoid a day with symptoms, euro 109/month to avoid asthma attacks that required emergency visits to their GP or the ER, and euro 94/month to achieve total avoidance of asthma symptoms compared with their current state.
CONCLUSIONS
This study presents European data regarding the importance to patients of different attributes of asthma and its treatment. Study participants placed high values on the avoidance of symptoms, and asthma attacks requiring medical attendance.
目的
本研究旨在了解英国、荷兰和西班牙哮喘患者对哮喘治疗不同方面的偏好。
方法
来自英国（n = 124）、荷兰（n = 269）和西班牙（n = 86）的哮喘患者参与了该调查。记录了患者对于特定数量的预防性吸入器的偏好以及支付意愿，这些偏好和支付意愿与每周出现症状的天数、需要使用缓解药物的天数、副作用风险以及去看全科医生（GP）或急诊室（ER）的需求有关。
结果
参与者愿意每月支付35欧元以避免出现一天症状，每月支付109欧元以避免哮喘发作需要紧急就医，与当前状态相比，每月支付94欧元以实现完全避免哮喘症状。
结论
本研究提供了有关哮喘及其治疗的不同属性对患者重要性的欧洲数据。研究参与者高度重视避免症状以及需要就医的哮喘发作。
Zotero 插件